top of page
Recent Policy Analysis on Value-Based Payment Models for Biopharmaceuticals and Related Issues
NEHI Reports, Statements, and Webinars 
Other Analyses Pertaining to Value-based Payment Models



  • National Academies’ recommendations on drug pricing throughout the drug supply chain; includes recommendations on value-based contracting “Making Medicines Affordable: A National Imperative,  The National Academies of Science, Engineering and Medicine, Committee on Ensuring Patient Access to Affordable Drug Therapies, November 2017












bottom of page